Axel Dignaß

IBD Essentials

We are dedicated IBD clinicians and researchers trying to bring you the latest updates in science and teaching of GI endoscopy. Host Axel Dignaß and his co-hosts Ailsa Hart, Iris Dotan and Florian Rieder speak with renown guest from all over the world. We are grateful to our sponsors abbvie and Olympus.

Vizitează neapărat site-ul podcastului și susține-i creatorul: ibd-essentials.com

Autor

Axel Dignaß

Categorie

Health

Site-ul podcastului

ibd-essentials.com

Cel mai nou episod

4 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

Treatment Targets in IBD 2026 and beyond 04.11.2026

Alessandro Armuzzi from Milano, Italy gives an exciting overview about current and future treatment options in IBD and also a look into the pipeline. Oral and parenteral options are discussed and the potential use of the available options in our current treatment paradigms

STRIDE-III: updated treatment targets in IBD 03.11.2026

Axel Dignass, Coordinator and senior author of STRIDE-III and host of IBD Essentials talks about development and key findings of the updated STRIDE-III framework, presented as latebreaker at UEGW 2026 in Barcelona and published on October 19/2026 in Lancet Gastroenterol Hepatol 2026; doi:10.1016/S2468-1253(26)00292-X

Optimal treatment strategy in Crohn's disease 21.10.2026

Nuru Noor, lead investigator of the Profile Study from the UK talks about the design and results of the Profile Study including longterm data and also about the concepts of early treatment, topdown strategies versus stepup approaches and prediction of disease courses in IBD

Epidemiology and management of microscopic colitis 07.10.2026

Andreas Münch from Linköping, Sweden, a leading expert in microscopic colitis talks about his journes in the area of microscopic colitis, management of microscopic colitis and the development of international guidelines on microscopic colitis

Pregnancy in IBD (2) 23.09.2026

Uma Mahadevan about Pregnancy in IBD

Inflammable bowel disease (IBD) in India 09.09.2026

Iris Dotan talks to Rupa Banerjee about the evolving landscape of inflammatory bowel disease (IBD) in India. Together, they explore current trends, challenges in diagnosis and treatment, and how the management of IBD is developing across the country. The conversation also highlights regional perspectives, clinical experiences, and what the future may hold for patients with IBD in India.

Pregnancy in IBD 26.08.2026

Iris Dotan and Mette Julsgaard about Pregnancy in IBD

Special Aspects of IBD management in Japan, monitoring strategies and medical treatment in IBD patients 12.08.2026

Taku Kobayashi from Tokyo talks about special aspects of IBD management in Japan, monitoring strategies and medical treatment in Japanese IBD patients including apheresis, tacrolimus, differences in the diseae course of Japanese and European patients with IBD and different managment strategies

The Stenova trial: A new treatment option with Ontunisertib in fibrostenosing CD 29.07.2026

Florian Rieder from Cleveland Clinic, Cleveland, USA, internationally renowned IBD, intestinal fibrosis expert and principal investigator of the new treatment option with the oral GI-restricted small molecule inhibitor of ALK-5 Ontunisertib in fibrostenosisng CD

Special Aspects of IBD management in South America, Early Surgery in Crohn's disease and the emerging role of robotic surgery in IBD surgery 15.07.2026

Paulo Kotze, Curtiba, Brazil, talks about special aspects of IBD management in South America, Early Surgery in Crohn's disease, appendectomy as a new treatment option in ulcerative colitis and the emerging role of robotic surgery in IBD surgery

Special Aspects of IBD management in the Middle-East and career pathways of women in GI and IBD 01.07.2026

Dr. Sara El Ouali, UAE, talks about the rise of IBD in the mid-east, special aspects of IBD management in the Middle-East and career pathways of women in GI and IBD, including gender disparities, difficult career paths for women and barriers of women in their career and the importance of mentoring programs

Biography and credos of Jean-Fred Colombel and strategies for prevention and very early modification of IBD 24.06.2026

Jean-Fred Colombel, Mount Sinai Hospital New York City, USA, talks about his biography and personal pathway in IBD and options of very early diagnosis of IBD and strategies to prevent the onset of IBD (interception) and early management of IBD

Biography of Bruce Sands and breaking the therapeutic ceiling in IBD 10.06.2026

Bruce Sands, Mount Sinai Hospital New York City, USA, talks about his biography and personal pathway in IBD and options of breaking the therapeutic ceiling in IBD including combination therapy, treat to target and early treatment

Management of postoperative Crohn's disease 27.05.2026

Matthieu Allez, Montreal, talks about the management of postoperative Crohn's disease, prediction of relapse rates, monitoring strategies in the postoperative setting, risk factors for postoperative recurrence and potential strategies to prevent recurrence

Recent BSGE guidelines of chromoendoscopy 13.05.2026

Pradeep Bhandari from Portsmouth (UK) on recent BSGE guidelines of chromoendoscopy, co-hosted by Raf Bisschops.

Recent clinical trial results informing clinical decision making for vedolizumab and anti-IL23 therapies 29.04.2026

Dr. Remo Panaccione, an internationally recognized expert in clinical trials discusses the recent data on vedolizumab and anti-IL23 therapies and how those changes impact clinical decision making in IBD

Relevance of cell-based therapies in IBD including hematopoetic stem cell transplantation and CAR T cell therapies 15.04.2026

Matthieu Allez, Montreal talks about cell-based therapeutic approaches in refractory or complicated IBD covering hematopoetic stem cell transplantation and CAR T cell therapies, indication for this treatment options, success rates and potential side effects and potential future approaches

Discussion about the role of B cells in health and other autoimmune diseases with highlighting the recent groundbreaking observations of B cell directed CART cell therapy in IBD 01.04.2026

Dr. Saurabh Mehandru, Mount Sinai Hospital in New York, internationally recognized physician scientist in IBD and global leader in B cell biology in intestinal health and inflammation discussed the role of B cells in intestinal homeostasis and IBD. Highliy relevant episode about a novel therapy that is entering IBD.

Introduction of Ailsa Hart as Co-Host of IBD Essentials and Management of Perianal Crohn's disease 18.03.2026

Ailsa Hart, St. Marks Hospital, London, UK, internationally renowned IBD expert talks about strategies to optimize the management of perianal fistulising Crohn's disease, relevance of MDT approaches, building international consortia, classification and optimized management of perianal fistulising CD

Introduction of Florian Rieder as Co-Host of IBD Essentials and Fibrosis in IBD: A new target for evaluation and treatment 04.03.2026

Florian Rieder from Cleveland Clinic, Cleveland, USA, internationally renowned IBD and intestinal fibrosis expert talks about his fundamental work and participation in intestinal fibrosis, spanning from basic research, clinical evaluation including establishing a fibrosis PRO, work on international consensus to evaluate intestinal fibrosis and new treatment options for intestinal fibrosis

How medical guidelines can improve the management of IBD 18.02.2026

Andreas Sturm, gastroenterologist and IBDand medical guideline expert from Berlin, discusses about the development of evidence based guidelines and the relevance to improve the management of patients with IBD and the implementation of guidelines into clinical practice.

Why should students and junior doctors pursue a career in IBD and how can UEG help? 04.02.2026

Paulo Sousa from Porto, current chair of the young talent group of UEG, reflects why she decided to become a gastroenterologist and to pursue a career in IBD. She describes how UEG may help tom foster a career in gastroenterology and why it may be useful to engage with UEG beyond UEGW

Emerging relevance of AI in the management of IBD 28.01.2026

Thomas Rösch, editor of Endoscopy Essentials and intgernationally renowned endoscopists discusses the potential role of AI to evaluate and standardize endoscopic disease activity in IBD and the potential repevance of clinical decision support tools to guide clinicians to choose the best treatment options in IBD patients

Role of nutrition in the etiopathogenesis and treatment of IBD 07.01.2026

Iris Dotan, Petah Tikva, Israel, former IOIBD president and international renowned expert in IBD and nutrition, discusses the role of nutrition in the pathogenesis of IBD and the potential of nutritional intervention to treat IBD and to modify the natural course of IBD

Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD 19.12.2025

Silvio Danese, Milan, internationally renowned IBD expert, former ECCO president and UEG Vice president discusses recent data from UEG 2025 on Etrasimod in mild UC (gladiator) and late breaking abstract data on obefazimod in ulcerative colitis

Ascultă podcastul IBD Essentials în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice